Your browser doesn't support javascript.
loading
Increased levels of anti-PfCSP antibodies in post-pubertal females versus males immunized with PfSPZ Vaccine does not translate into increased protective efficacy.
Kc, Natasha; Church, L W Preston; Riyahi, Pouria; Chakravarty, Sumana; Seder, Robert A; Epstein, Judith E; Lyke, Kirsten E; Mordmüller, Benjamin; Kremsner, Peter G; Sissoko, Mahamadou S; Healy, Sara; Duffy, Patrick E; Jongo, Said A; Nchama, Vicente Urbano Nsue Ndong; Abdulla, Salim; Mpina, Maxmillian; Sirima, Sodiomon B; Laurens, Matthew B; Steinhardt, Laura C; Oneko, Martina; Li, MingLin; Murshedkar, Tooba; Billingsley, Peter F; Sim, B Kim Lee; Richie, Thomas L; Hoffman, Stephen L.
Afiliação
  • Kc N; Sanaria Inc., Rockville, MD, United States.
  • Church LWP; Sanaria Inc., Rockville, MD, United States.
  • Riyahi P; Sanaria Inc., Rockville, MD, United States.
  • Chakravarty S; Sanaria Inc., Rockville, MD, United States.
  • Seder RA; Vaccine Research Center, National Institute of Heath, Bethesda, MD, United States.
  • Epstein JE; Naval Medical Research Center (NMRC), Silver Spring, MD, United States.
  • Lyke KE; Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, United States.
  • Mordmüller B; Institut für Tropenmedizin, Eberhard Karls Universität Tübingen and German Center for Infection Research, Tübingen, Germany.
  • Kremsner PG; Department of Medical Microbiology, Radboud University Medical Center, Nijmegen, Netherlands.
  • Sissoko MS; Institut für Tropenmedizin, Eberhard Karls Universität Tübingen and German Center for Infection Research, Tübingen, Germany.
  • Healy S; Centre de Recherches Medicales de Lambaréné, Lambaréné, Gabon.
  • Duffy PE; Malaria Research and Training Center (MRTC), Mali National Institute of Allergy and Infectious Diseases International Centers for Excellence in Research, University of Science, Techniques and Technologies of Bamako, Bamako, Mali.
  • Jongo SA; Laboratory of Malaria Immunology and Parasitology, National Institutes of Allergy and Infectious Diseases, National Institutes of Health (LMIV/NIAID/NIH), Rockville, MD, United States.
  • Nchama VUNN; Laboratory of Malaria Immunology and Parasitology, National Institutes of Allergy and Infectious Diseases, National Institutes of Health (LMIV/NIAID/NIH), Rockville, MD, United States.
  • Abdulla S; Bagamoyo Research and Training Centre, Ifakara Health Institute, Bagamoyo, Tanzania.
  • Mpina M; Ministry of Health and Social Welfare, Malabo, Equatorial Guinea.
  • Sirima SB; Bagamoyo Research and Training Centre, Ifakara Health Institute, Bagamoyo, Tanzania.
  • Laurens MB; Bagamoyo Research and Training Centre, Ifakara Health Institute, Bagamoyo, Tanzania.
  • Steinhardt LC; Swiss Tropical Public Health Institute, Basel, Switzerland.
  • Oneko M; University of Basel, Basel, Switzerland.
  • Li M; Groupe de Recherche Action en Santé, Ouagadougou, Burkina Faso.
  • Murshedkar T; Centre National de Recherche et de Formation sur le Paludisme, Ouagadougou, Burkina Faso.
  • Billingsley PF; Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, United States.
  • Sim BKL; Malaria Branch, Division of Parasitic Diseases and Malaria, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, GA, United States.
  • Richie TL; Kenya Medical Research Institute, Centre for Global Health Research, Kisumu, Kenya.
  • Hoffman SL; Sanaria Inc., Rockville, MD, United States.
Front Immunol ; 13: 1006716, 2022.
Article em En | MEDLINE | ID: mdl-36389797

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Malária Falciparum / Vacinas Antimaláricas / Malária Limite: Adult / Animals / Child / Female / Humans / Infant / Male Idioma: En Ano de publicação: 2022

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Malária Falciparum / Vacinas Antimaláricas / Malária Limite: Adult / Animals / Child / Female / Humans / Infant / Male Idioma: En Ano de publicação: 2022